Collectively, the data demonstrated that sGC deletion decreased TGFβ1 expression in the vascular niche, consequently reprogrammed adjacent CAFs into CD105neg apCAFs, potentially contributing to the observed phenotype of reduced tumor growth. This evidence concerns the gene TGFB1 and neoplasm.